Biotech

All Articles

Metsera associate with Amneal to lock down GLP-1 supply

.Along with early phase 1 records now out in the wild, metabolic illness ensemble Metsera is actuall...

Rivus articles data to back up muscle-sparing being overweight medicine cases

.Rivus Pharmaceuticals has introduced the records responsible for its phase 2 being overweight gain ...

BMS pays for $110M to develop T-cell treatment deal, helping Top buy opportunity to improve prioritized pipeline

.Bristol Myers Squibb is paying for Prime Medicine $110 million beforehand to create reagents for ex...

Generate gains yet another $1B-plus Large Pharma collaboration

.Novartis has inked an offer possibly worth greater than $1 billion with Flagship-founded Generate: ...

Metsera GLP-1 information cut discloses 7.5% weight loss at 36 days

.Lately debuted Metsera is actually unfolding some period 1 information for its own GLP-1 receptor a...

Flagship hopes biotechs group to Mirai to improve hereditary meds

.In the middle of the genetic medications branches ethnicity, Crown jewel Pioneering is actually rev...

BioAge eyes $180M coming from IPO, exclusive placement for being overweight tests

.BioAge Labs is actually checking out around $180 thousand in preliminary proceeds from an IPO and a...

Merck's LAG-3 combo falls short colorectal cancer phase 3 research study

.An attempt by Merck &amp Co. to open the microsatellite dependable (MSS) metastatic intestines canc...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Partners has closed a fund of 180 million europeans ($ 200 million), money that ...

BioAge produces $198M from IPO as weight problems biotech joins Nasdaq

.BioAge Labs is actually generating almost $200 million via its own Nasdaq IPO today, with the proce...